首页> 外国专利> Novel 4-cyano, 4-amino and 4-aminomethyl of pyrazolo 1,5-a pyridines, pyrazolo 1,5-c pyrimidines and 2h-indazol and derivatives 5-cyano, 5-amino 5-aminomethyl and imidazo 1,2-a pyridines and imidazo 1,5-a pyrazines as inhibitors of cyclin dependent kinase.

Novel 4-cyano, 4-amino and 4-aminomethyl of pyrazolo 1,5-a pyridines, pyrazolo 1,5-c pyrimidines and 2h-indazol and derivatives 5-cyano, 5-amino 5-aminomethyl and imidazo 1,2-a pyridines and imidazo 1,5-a pyrazines as inhibitors of cyclin dependent kinase.

机译:吡唑并[1,5-a]吡啶,吡唑并[1,5-c]嘧啶和2h-吲唑的新型4-氰基,4-氨基和4-氨基甲基及其衍生物5-氰基,5-氨基5-氨基甲基和咪唑[1,2-a]吡啶和咪唑并[1,5-a]吡嗪作为细胞周期蛋白依赖性激酶的抑制剂。

摘要

A compound represented by the structural formula: or a pharmaceutically acceptable salt or solvate thereof, wherein: X is C or N; Y is selected from the group consisting of CN, NH2, and CH2NH2; R 1 is selected from the group consisting of H, halogen, R9, NH2, CN, alkyl, alkenyl, alkynyl, aryl, heteroaryl, CF3, heterciclilalquilo, arylalkyl, heteroarylalkyl, heterociclilalquilalquilo, cicloalqulo, cycloalkylalkyl, C (O) OR 4, alkyl substituted with 1 to 6 groups R 9 which may be the same or different and are independently selected from the list of R 9 shown below, and wherein the aryl in the definitions indicated above for R 1 can be unsubstituted or optionally substituted with one or more moieties which can be the same or different, each moiety being independently selected from the group consisting of halogen, CN, NH2, -OR 5, SR 5, -CH 2 oR 5, -C (O) R 5, -SO3H, -S (O2) R 6, -S (O 2) NR 5 R 6, - NR 5 R 6, -C (O) NR 5 R 6, -CF 3 and -OCF 3; R 2 is selected from the group consisting of H, halogen, -NR 5 R 6, - C (O) OR 4, -C (O) NR 5 R 6, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, aryl, arylalkyl, heterocyclyl, heterocyclylalkyl, wherein each of said moieties of alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heterocyclylalkyl, heteroaryl and heteroarylalkyl for R 2 and heterocyclyl, whose structures are shown immediately above for R 2, can be unsubstituted or optionally independently substituted with one or more moieties which can be the same or different, selected each moiety being independently from the group consisting of halogen, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, CF3, CN, -OCF3, - (CR 4 R 5) n OR 6, - OR 5, -R 5 OR 5, -NR 5 R 6, - (CR 4 R 5) nNR 5 R 6, -C (O2) R 5, -C (O) R 5, -C (O) NR 6 R 6, -SR 6, -S (O 2) R 6, -S (O 2) NR 5 R 6, -N (R 5) S (O2) R7, -N (R 5) C (O) R 7 and - N (R 5) C (O) NR 5 R 6; R3 is selected from the group consisting of amino, C alkylamino, arylalkylamino, heteroarylamino, heteroarylalkylamino, hydroxyalkylamino, heterocycloalkylalkylamino, wherein each of said amino, alkylamino, cycloalkylamino, arylalkylamino, heteroarylamino, heteroarylalkylamino, hydroxyalkylamino, and heterocycloalkylalkylamino can be unsubstituted or optionally independently substituted with one or more moieties which can be the same or different, selected each moiety being independently from the group consisting of halogen, alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, heteroarylalkyl, heterocycloalkyl-alkyl, cycloalkyl, CF3 , OCF3, CN, -OR 5, -NR 5 R 6, -C (R 4 R 5) n OR 5, -C (O2) R 5, -C (O) R 5, -C (O) NR 5 R 6, -SR 6, -S (O 2) R 7, -S (O 2) NR 5 R 6, -N (R 5) S (O2) R 7, - N (R 5) C (O) R 7 and -N (R 5) C (O) NR 5 R 6; R 4 is H, halogen, CN or alkyl; R 5 is H or alkyl; R 6 is selected from the group consisting of H, alkyl, aryl, arylalkyl, cycloalkyl, heterocycloalkyl, heteroaryl and heteroarylalkyl, wherein each of said alkyl, aryl, arylalkyl, cycloalkyl, heterocycloalkyl, heteroaryl and heteroarylalkyl can be without unsubstituted or optionally substituted with one or more moieties which can be the same or different, each moiety being selected from the group consisting of halogen, alkyl, aryl, cycloalkyl, CF3, OCF3, CN, -OR 5, -NR 5 R 10, - N (R6) Boc, - (CR 4 R 5) n OR 5, -C (O2) R 5, - C (O) R 5, -C (O) NR 5 R 10, -SO3H, - SR 10, - S (O2) R 7, -S (O 2) NR 5 R 10, -N (R 5) S (O2) R7, -N (R5) C (O) R 7 and - N (R 5) C ( O) NR 5 R 10; R 10 is selected from the group consisting of H, alkyl, aryl, arylalkyl, cycloalkyl, heterocycloalkyl, heteroaryl and heteroarylalkyl, wherein each of said alkyl, aryl, arylalkyl, cycloalkyl, heterocycloalkyl, heteroaryl and heteroarylalkyl, which may be unsubstituted or optionally substituted with one or more moieties which can be the same or different, selected each other from the group consisting of halogen, alkyl, aryl, cycloalkyl, CF3, OCF3, CN, -OR 5, - NR 4 R 5, - N (R 5) Boc, - (CR 4 R 5) n OR 5, -C (O2) R 5, -C (O) NR 4 R 5, -C (O) R 5, SO 3 H, -SR 5, - S (O2) R7, -S (O2) NR 4 R 5, -N (R 5) S (O2) R 7, -N (R 5) C (O) R 7 and - N (R 5) C (O) NR 4 R 5; optionally (i) R 5 and R 10 in the moiety -NR 5 R 10, or (ii) R 5 and R 6 in the moiety -NR 5 R 6 can be joined to form a cycloalkyl or heterocycloalkyl, each of said cycloalkyl or heterocycloalkyl is unsubstituted or optionally independently substituted with one or more groups R 9; R 7 can be unsubstituted or optionally independently substituted with one or more moieties which can be the same or different, each moiety being selected from the group consisting of halogen, alkyl, aryl, cycloalkyl, CF3, OCF3, CN, -OR 5, -NR 5 R 10, - CH2OR 5, -C (O2) R 5, -C (O) NR 5 R 10, -C (O) R 5, -SR 10, -S (O 2) R 10, - S (O2 ) NR 5 R 10, -N (R 5) S (O2) R 10, -N (R 5) C (O) R 10 and -N (R 5) C (O) NR 5 R 10; R 8 is selected from the group consisting of R 6, -C (O) NR 5 R 10, - CH2OR 4, -C (O) OR 6, -C (O2) R 7 and S (O2) R 7; R 9 is selected from the group consisting of halogen, -CN, -NR 5 R 6, - (CH 2) n 4 - (CO2) R 6, -C (O) NR 5 R 6, -OR 6, - SR 6, -S (O 2) R 7, -S (O 2) NR 5 R 6, -N (R 5) S (O2) R 7, -N (R 5) C (O) R 7 and -N ( R 5) C (O) NR 5 R 6; m is 0 to 4; n is 1 to 4, in which, unless otherwise, each of the aryl, heteroaryl, cycloalkyl and heterocyclyl in the definitions indicated above may be optionally substituted by one or more system substituents indicated ring are identical or different, each being independently selected from the group consisting of aryl, heteroaryl, aralkyl, alkylaryl, heteroaralkyl, alkylheteroaryl, hydroxy, hydroxyalkyl, alkoxy, aryloxy, aralkoxy, acyl, aroyl, halo, nitro, cyano, carboxyl, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, alkylthio, arylthio, heteroarylthio, aralkylthio, heteroaralkylthio, cycloalkyl, heterocyclyl, Y1Y2N-, Y1Y2N-alkyl-, Y1Y2NC (O) - and Y1Y2NSO2-, wherein Y1 and Y2 are same or different and are independently selected from the group consisting of hydrogen, alkyl, aryl and aralkyl.
机译:由结构式表示的化合物:或其药学上可接受的盐或溶剂化物,其中:X为C或N; Y选自CN,NH 2和CH 2 NH 2; R 1选自H,卤素,R 9,NH 2,CN,烷基,烯基,炔基,芳基,杂芳基,CF 3,杂环烷基,芳基烷基,杂芳基烷基,杂环烷基芳基,环烷基,环烷基烷基,C(O)OR 4,被1-6个R 9基团取代的烷基,R 6可以相同或不同,并且独立地选自下面显示的R 9的列表,并且其中对于R 1的上述定义中的芳基可以是未取代的或任选地被一个或多个取代。可以相同或不同的更多部分,每个部分独立地选自卤素,CN,NH 2,-OR 5,SR 5,-CH 2 oR 5,-C(O)R 5,-SO3H, -S(O 2)R 6,-S(O 2)NR 5 R 6,-NR 5 R 6,-C(O)NR 5 R 6,-CF 3和-OCF 3; R 2选自:H,卤素,-NR 5 R 6,-C(O)或4,-C(O)NR 5 R 6,烷基,烯基,炔基,环烷基,环烷基烷基,杂芳基,芳基,芳基烷基,杂环基,杂环基烷基,其中对于R 2而言,其烷基,烯基,炔基,环烷基,芳基,芳基烷基,杂环基烷基,杂芳基和杂芳基烷基的每个所述基团的结构在R 2的正上方可以是未取代的或任选地独立地被一个或多个可以相同或不同的部分取代,每个部分独立地选自卤素,烷基,烯基,炔基,芳基,环烷基,CF 3,CN,-OCF 3,-(CR 4 R 5)n OR 6,-OR 5,-R 5 OR 5,-NR 5 R 6,-(CR 4 R 5)nNR 5 R 6,-C(O2)R 5,-C(O)R 5, -C(O)NR 6 R 6,-SR 6,-S(O 2)R 6,-S(O 2)NR 5 R 6,-N(R 5)S(O2)R7,-N(R 5)C(O)R 7和-N(R 5)C(O)NR 5 R 6; R 3选自氨基,C 1-烷基氨基,芳基烷基氨基,杂芳基氨基,杂芳基烷基氨基,羟基烷基氨基,杂环烷基烷基氨基,其中所述氨基,烷基氨基,环烷基氨基,芳基烷基氨基,杂芳基氨基,杂芳基烷基氨基,羟基烷基氨基和杂环烷基烷基氨基中的每一个可以是未取代的或任选独立地取代的具有一个或多个相同或不同的部分,每个部分独立地选自卤素,烷基,芳基,杂芳基,环烷基,杂环烷基,杂芳基烷基,杂环烷基-烷基,环烷基,CF 3,OCF 3,CN-或5,-NR 5 R 6,-C(R 4 R 5)n或5,-C(O2)R 5,-C(O)R 5,-C(O)NR 5 R 6,-SR 6 ,-S(O 2)R 7,-S(O 2)NR 5 R 6,-N(R 5)S(O2)R 7,-N(R 5)C(O)R 7和-N( R 5)C(O)NR 5 R 6; R 4是H,卤素,CN或烷基; R 5为H或烷基; R 6选自由H,烷基,芳基,芳基烷基,环烷基,杂环烷基,杂芳基和杂芳基烷基组成的组,其中所述烷基,芳基,芳基烷基,环烷基,杂环烷基,杂芳基和杂芳基烷基中的每一个可以不被未取代或任选地被取代。一个或多个可以相同或不同的部分,每个部分选自卤素,烷基,芳基,环烷基,CF 3,OCF 3,CN,-OR 5 --NR 5 R 10,-N(R6) Boc,-(CR 4 R 5)n OR 5,-C(O2)R 5,-C(O)R 5,-C(O)NR 5 R 10,-SO3H,-SR 10,-S(O2 )R 7,-S(O 2)NR 5 R 10,-N(R 5)S(O2)R7,-N(R5)C(O)R 7和-N(R 5)C(O)NR 5 R 10; R 10选自H,烷基,芳基,芳基烷基,环烷基,杂环烷基,杂芳基和杂芳基烷基,其中所述烷基,芳基,芳基烷基,环烷基,杂环烷基,杂芳基和杂芳基烷基中的每一个可以是未取代的或任选取代的具有一个或多个相同或不同的部分,彼此选自卤素,烷基,芳基,环烷基,CF3,OCF3,CN,-OR 5,-NR 4 R 5,-N(R 5 )Boc,-(CR 4 R 5)n OR 5,-C(O2)R 5,-C(O)NR 4 R 5,-C(O)R 5,SO 3 H,-SR 5,-S (O2)R7,-S(O2)NR 4 R 5,-N(R 5)S(O2)R 7,-N(R 5)C(O)R 7和-N(R 5)C(O )NR 4 R 5;任选地,(i)-NR 5 R 10部分中的R 5和R 10,或(ii)-NR 5 R 6部分中的R 5和R 6可以连接形成环烷基或杂环烷基,每个所述环烷基或杂环烷基未被取代或任选地被一个或多个R 9基团独立地取代; R 7可以是未取代的或任选地被一个或多个相同或不同的部分独立地取代,每个部分选自卤素,烷基,芳基,环烷基,CF3,OCF3,CN,-OR 5- NR 5 R 10,-CH2OR 5,-C(O2)R 5,-C(O)NR 5 R 10,-C(O)R 5,-SR 10,-S(O 2)R 10,-S (O2)NR 5 R 10,-N(R 5)S(O2)R 10,-N(R 5)C(O)R 10和-N(R 5)C(O)NR 5 R 10; R 8选自:R 6,-C(O)NR 5 R 10,-CH 2 OR 4,-C(O)OR 6,-C(O 2)R 7和S(O 2)R 7。 R 9选自卤素,-CN,-NR 5 R 6,-(CH 2)n 4-(CO2)R 6,-C(O)NR 5 R 6,-OR 6,-SR 6,-S(O 2)R 7 ,-S(O 2)NR 5 R 6,-N(R 5)S(O2)R 7,-N(R 5)C(O)R 7和-N(R 5)C(O)NR 5 R 6; m为0至4; n为1至4,其中除非另有说明,否则上述指示的定义中的每个芳基,杂芳基,环烷基和杂环基可以任选地被一个或多个指示为相同或不同的环的系统取代基取代,各自独立地选自芳基,杂芳基,芳烷基,烷基芳基,杂芳烷基,烷基杂芳基,羟基,羟烷基,烷氧基,芳氧基,芳烷氧基,酰基,芳酰基,卤素,硝基,氰基,羧基,烷氧基羰基,芳氧基羰基,芳烷氧基羰基,烷基磺酰基,芳基磺酰基,杂芳基,芳硫基,杂芳基硫基,芳烷硫基,杂芳烷硫基,环烷基,杂环基,Y 1 Y 2 N-,Y 1 Y 2 N-烷基-,Y 1 Y 2 NC(O)-和Y 1 Y 2 NSO 2-,其中Y 1和Y 2相同或不同,并且独立地选自氢,烷基,芳基和芳烷基。

著录项

  • 公开/公告号ES2349476T3

    专利类型

  • 公开/公告日2011-01-03

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号ES20060802808T

  • 发明设计人 MALLAMS ALAN;MADISON VINCENT;PARUCH KAMIL;

    申请日2006-08-31

  • 分类号C07D231/56;A61K31/416;A61K31/437;A61P29;A61P35;C07D401/12;C07D471/04;C07D487/04;

  • 国家 ES

  • 入库时间 2022-08-21 18:02:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号